Abstract: The present invention relates to bicyclic imidazole compounds of general formula wherein R1 to R3 and A are defined as in claims 1 to 8, the tautomers, the enantiomers, the stereoisomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
Type:
Grant
Filed:
December 21, 2004
Date of Patent:
February 27, 2007
Assignee:
Boehringer Ingelheim International GmbH
Inventors:
Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Norbert Hauel, Mohammad Tadayyon, Leo Thomas